Wells Fargo analyst Stan Berenshteyn raised the firm’s price target on Doximity (DOCS) to $55 from $43 and keeps an Equal Weight rating on the shares. The firm says it doubts anyone was surprised by the Q3 beat and raise, but management cautioned on extrapolating glide path into FY26, noting historically the norm has been “2-turns performance vs the market,” while 2025 is trending to 3-turns, with market growth estimate at about 7%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCS: